French Chemicals Stock News

Arkema (ENXTPA:AKE) opened 2026 with Q1 revenue of €2.2b and basic EPS of €0.36, as investors weigh these fresh numbers against a trailing 12 month EPS of €0.23 on €8.9b of revenue and a net income of €17m that reflects thin profitability. Over the last year, a reported net profit margin of 0.2% and a large one off loss in the trailing figures have kept earnings in focus, while analysts in the dataset still see scope for earnings growth ahead. Overall, the latest quarter keeps attention...

Optimism over a potential resolution to the Middle East conflict is lifting expectations for international travel and luxury spending. This improved sentiment is feeding through to Hermès International Société en commandite par actions (ENXTPA:RMS) and the wider European luxury sector. Investors are reassessing demand prospects for high-end goods as travel dependent spending comes back into focus. Hermès shares last closed at €1,671.5, with the stock up 4.0% over the past week but showing...

If you are wondering whether L'Oréal's current share price reflects its true worth, you are not alone, especially with valuation tools often sending mixed signals. The stock most recently closed at €373.40, with returns of 2.1% over the past week, 4.2% over the past month, 2.4% year to date, 1.7% over 1 year, negative 5.7% over 3 years, and 16.9% over 5 years. Recent coverage of L'Oréal has focused on its position as a global beauty leader and how it is adapting product lines and marketing...

Wondering whether ABIVAX Société Anonyme at €110.20 is priced attractively or already reflecting a lot of optimism? This article walks through the key signals that matter for you as a shareholder or prospective investor. The stock has shown sharp moves, with a 17.9% return over the last 7 days, 8.7% over 30 days, a 4.2% decline year to date, and a very large 1-year return that is around 17x. These swings in the share price often reflect changing expectations about the company, its pipeline...

SEB stock in focus after recent gains SEB (ENXTPA:SK) has come into focus for investors after a recent share price move, with the stock up around 4% over the past week and over 20% in the past month. See our latest analysis for SEB. That short term momentum, including a 1 month share price return of 21.29% and a year to date share price return of 9.29%, contrasts with a 1 year total shareholder return decline of 32.74%, so recent strength is emerging against a weaker longer term record. If...

EssilorLuxottica Société anonyme (ENXTPA:EL) has just had its General Meeting approve a €4.00 per share dividend for the 2025 financial year, with investors also offered the option of receiving this payout in shares. See our latest analysis for EssilorLuxottica Société anonyme. That backdrop of shareholder friendly moves, including the dividend and recent share buybacks, comes after a year where the stock has lost momentum, with a 1-year total shareholder return decline of 25.78% despite a...

The European markets have shown a mixed performance, with the pan-European STOXX Europe 600 Index ending the week slightly up amid ongoing geopolitical tensions and economic uncertainties. Amid these broader market conditions, investors often look for opportunities beyond established names, and penny stocks can offer intriguing possibilities. While the term "penny stock" might seem outdated, it still signifies smaller or newer companies that can present unique opportunities. We've identified...

As the European market navigates a landscape marked by stalled negotiations in the Middle East and fluctuating oil prices, investors are keeping a close eye on opportunities that can provide stability and growth. In this environment, dividend stocks stand out as they offer potential income streams while contributing to portfolio diversification amidst economic uncertainties.

Sanofi (ENXTPA:SAN) has drawn fresh attention after new REMODEL Phase 4 data for Dupixent in eosinophilic esophagitis, with clinically meaningful improvements in esophageal function and structure compared with placebo at week 24. See our latest analysis for Sanofi. Despite the fresh Dupixent data and other recent updates, such as the planned Dynavax acquisition, the Toronto AI expansion and a higher ordinary dividend, Sanofi’s short term share price return has been weak, with longer term...

Investors may be wondering if Engie at €27.57 is still offering value after its strong run, or if most of the easy gains are already behind it. The stock has seen a 1.9% decline over the last 7 days and a 4.8% decline over the last 30 days, but its year-to-date return sits at 20.0%, with 57.4% over 1 year, 134.8% over 3 years and 247.1% over 5 years. Recent news coverage has focused on Engie as a major European utilities group, often highlighting its role in power generation, energy...

TotalEnergies has introduced its new Pangea 5 supercomputer, developed with Dell Technologies and NVIDIA. The system is designed to multiply the company’s computing power by six for subsurface imaging and AI driven research. Pangea 5 is configured to reuse waste heat to warm buildings at the research center, aiming to cut the carbon footprint of computing. TotalEnergies (ENXTPA:TTE) is adding heavy digital firepower with Pangea 5 at a time when the stock trades around €76.75 and has...

If you are wondering whether Veolia Environnement at €36.20 is still reasonably priced or starting to look expensive, a closer look at its valuation tools can help frame your next move. The stock has returned 4.0% over the last week, 8.2% over the last month, 20.1% year to date and 19.3% over the past year, which gives useful context before weighing what you are paying today. Recent coverage has focused on Veolia's position as a major utilities provider and on how investors are assessing its...

Why AXA’s Q1 2026 update matters for shareholders AXA (ENXTPA:CS) just reported its Q1 2026 sales and trading update, with gross written premiums and other revenues at €37.95b, 6% higher year on year, supported by property and casualty plus life and health lines. See our latest analysis for AXA. The Q1 update comes as AXA’s share price has gained 3.9% over the past week and 5.9% over the last 90 days, while the 5 year total shareholder return of 133.42% points to strong long term...

The subdued market reaction suggests that TotalEnergies EP Gabon Société Anonyme's ( EPA:EC ) recent earnings didn't...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

It looks like Rexel S.A. ( EPA:RXL ) is about to go ex-dividend in the next 3 days. Typically, the ex-dividend date is...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Celebrations may be in order for Obiz S.A. ( EPA:ALBIZ ) shareholders, with the analysts delivering a significant...

The market for Alten S.A.'s ( EPA:ATE ) shares didn't move much after it posted weak earnings recently. Our analysis...

Advicenne S.A. ( EPA:ALDVI ) is possibly approaching a major achievement in its business, so we would like to shine...

For readers wondering whether Vinci is priced attractively right now, or if the recent run means the easy value is gone, this article focuses squarely on what the current share price might imply. The stock last closed at €133.50, with returns of 5.8% over 7 days, 1.4% over 30 days, 10.2% year to date, 10.4% over 1 year, 37.6% over 3 years and 71.3% over 5 years. This naturally raises questions about how much value might already be reflected in the price. Recent coverage has centered on...

SCOR (ENXTPA:SCR) has just posted its Q1 2026 numbers, with revenue of about €3.1b and basic EPS of €1.26, setting the tone for how margins are holding up early in the year. Over recent quarters, revenue has moved between €3.0b and €6.8b while quarterly basic EPS has ranged from €1.12 to €1.30, giving you a clear view of how the top line and per share profitability have tracked together into this latest print. With trailing 12 month EPS at €4.89 and net income of €876m, the focus now is on...

Alstom (ENXTPA:ALO) has secured a €295 million contract with Transports publics de la région lausannoise to upgrade Lausanne’s m2 metro line, focused on next generation CBTC signalling and mid life fleet modernisation. See our latest analysis for Alstom. The contract news comes as Alstom’s 1 day share price return of 3.08% and 7 day return of 7.33% contrast with a 30 day share price return decline of 27.56% and a 1 year total shareholder return decline of 17.66%, pointing to short term...

In the first quarter of 2026, BNP Paribas reported net interest income of €14,056 million and net income of €3,217 million, and confirmed that its total MREL ratio of 29.7% sits well above newly updated ACPR regulatory thresholds. This combination of earnings growth and a sizeable capital buffer under the revised MREL regime underlines the group’s capacity to absorb shocks while continuing to support clients and regulatory initiatives like outcome-linked bonds and loan-market...